172 related articles for article (PubMed ID: 37189217)
1. A frequentist approach to dynamic borrowing.
Li R; Lin R; Huang J; Tian L; Zhu J
Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
[TBL] [Abstract][Full Text] [Related]
2. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
[TBL] [Abstract][Full Text] [Related]
3. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
4. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
5. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
Fu C; Pang H; Zhou S; Zhu J
Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
[TBL] [Abstract][Full Text] [Related]
6. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
Li H; Tiwari R; Li QH
J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
[TBL] [Abstract][Full Text] [Related]
7. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
[TBL] [Abstract][Full Text] [Related]
8. A frequentist design for basket trials using adaptive lasso.
Kanapka L; Ivanova A
Stat Med; 2024 Jan; 43(1):156-172. PubMed ID: 37919834
[TBL] [Abstract][Full Text] [Related]
9. Robust incorporation of historical information with known type I error rate inflation.
Calderazzo S; Wiesenfarth M; Kopp-Schneider A
Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
[TBL] [Abstract][Full Text] [Related]
10. Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseases.
Sebastien B
J Pharmacokinet Pharmacodyn; 2023 Dec; 50(6):495-499. PubMed ID: 37148459
[TBL] [Abstract][Full Text] [Related]
11. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
Kaplan D; Chen J; Yavuz S; Lyu W
Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
[TBL] [Abstract][Full Text] [Related]
12. Bayesian sample size determination in basket trials borrowing information between subsets.
Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
[TBL] [Abstract][Full Text] [Related]
13. Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.
Zheng H; Wason JMS
Biostatistics; 2022 Jan; 23(1):120-135. PubMed ID: 32380518
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian Approach for Summarizing and Modeling Time-Series Exposure Data with Left Censoring.
Houseman EA; Virji MA
Ann Work Expo Health; 2017 Aug; 61(7):773-783. PubMed ID: 28810680
[TBL] [Abstract][Full Text] [Related]
15. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
16. Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug development.
Wu Y; Hui J; Deng Q
Pharm Stat; 2020 Nov; 19(6):787-802. PubMed ID: 32573051
[TBL] [Abstract][Full Text] [Related]
17. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
18. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
19. BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.
Bi D; Liu M; Lin J; Liu R
Stat Med; 2023 Dec; 42(30):5708-5722. PubMed ID: 37858287
[TBL] [Abstract][Full Text] [Related]
20. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
Liu GF
Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
